Biotech
Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
More
New oral insulin tech replaces needles with nanoparticles
If the success of a new oral insulin delivery system in rats translates to people, it could entice more diabetics to pursue insulin therapy.
Game triggers auditory hallucinations in mice and people
An experimental game that triggers auditory hallucinations in both mice and humans could lead to new treatments for schizophrenia.
A single gene turns on humans' rapid brain growth
Researchers have looked at gene expression in human brain organoids compared to other apes to discover the genetic mechanism crucial to triggering the human brain’s rapid growth.
New approach for mRNA HIV vaccine passes first human trial
There is currently no HIV vaccine, but a new technique which produced specific immunity cells in humans may pave the way to one.
Penn scientists correct genetic blindness with a single injection into the eye
Antisense oligonucleotide therapy uses small molecules to alter RNA. Researchers have now used those molecules to alleviate a genetic form of blindness.
Nobel prize-winning chemist helps invent synthetic mucus
Mucins, the long proteins in mucus, have an array of bacteria-fighting properties. These artificial mucins can act like the real thing.
How scientists finally got gene therapy to work
Gene therapy shows promise for treating diseases and the longstanding mysteries of medical science. But what is gene therapy and how does it work?
Injectable “glue” helps heal traumatic brain injury in rats
By injecting a “brain glue” into rats, researchers were able to speed up their recovery after a traumatic brain injury.
A major Huntington’s trial has failed. Here’s why there is still hope.
A simple genetic test can determine a person’s fate for one of the worst diseases on the planet. But research offers new hope for Huntington’s disease.
Argentina’s songbirds explain a mysterious type of speciation
With the help of a group of songbirds, researchers have uncovered the mystery of an evolutionary process called “sympatric speciation.”
Pfizer’s COVID-19 vaccine 100% effective in adolescent study
Pfizer’s COVID-19 vaccine was reportedly 100% effective in a trial involving more than 2,000 adolescents between the ages of 12 and 15.
New cancer treatment uses “hot blood cells” to target tumors
A new cancer treatment combining immunotherapy, photothermal therapy, and modified blood cells was highly effective in mice.
The next generation of living machines: xenobots 2.0
Made from the stem cells of a frog, “Xenobots” are tiny living machines. And researchers have just debuted version 2.0.
These color-changing sutures can catch infections
Iowa high school senior Dasia Taylor has invented color-changing sutures that can catch an infection early.
Deep brain stimulation: explained
Deep brain stimulation is being studied as a treatment for any number of neurological and psychological conditions. But what is it, exactly?
Wireless brain-computer interface moves out of the lab
A new wireless brain-computer interface was able to record and transmit brain signals as effectively as the “gold standard” wired systems.
Extreme E is bringing electric SUV racing to the ends of the Earth
With climate change and gender equity at its core, Extreme E is bringing electric SUV racing to the wild.
Therapeutic bed could help prevent brain damage in babies
Calmer is a therapeutic bed for incubators that simulates a caregiver’s breathing and heartbeat to relieve stress in newborns.
An IBM quantum computer is being built at a US hospital
An IBM quantum computer is being installed at the Cleveland Clinic as part of the organizations’ Discovery Accelerator collaboration.
Series|
Catalysts
Research grants, the silicon valley way
What if there was a way to fast-forward innovation? An economist and tech billionaire recently joined forces to make research grants available within 14 days.
Subscribe to the newsletter